Zeitschriftenartikel zum Thema „GLS1“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "GLS1" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Vidula, Neelima, Christina Yau und Hope S. Rugo. „Glutaminase (GLS) expression in primary breast cancer (BC): Correlations with clinical and tumor characteristics.“ Journal of Clinical Oncology 37, Nr. 15_suppl (20.05.2019): 558. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.558.
Der volle Inhalt der QuelleRojas, Livisu Pajares, und Claudia Machicado Rivero. „Abstract 883: Glutaminases expression and viral infection as potential prognostic factors in cervical, head and neck and liver cancers“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 883. http://dx.doi.org/10.1158/1538-7445.am2023-883.
Der volle Inhalt der QuelleBright, Scott J., Rishab Kolachina, Mariam Ben Kacem, Mandira Manandhar, Philip Jones, Timothy A. Yap, Steven H. Lin und Gabriel O. Sawakuchi. „Abstract B030: Modulating mitochondria metabolism to radiosensitize KEAP1 mutated non-small cell lung cancer“. Cancer Research 84, Nr. 1_Supplement (09.01.2024): B030. http://dx.doi.org/10.1158/1538-7445.dnarepair24-b030.
Der volle Inhalt der QuelleXiao, Yangbo, Rong Huang, Shenping Cao, Dafang Zhao, Zhuangwen Mao, Chuchu Xiao, Zhehua Xu et al. „Molecular Characterization and Dietary Regulation of Glutaminase 1 (gls1) in Triploid Crucian Carp (Carassius auratus)“. Fishes 7, Nr. 6 (07.12.2022): 377. http://dx.doi.org/10.3390/fishes7060377.
Der volle Inhalt der QuelleMyint, Zin W., Ramon C. Sun, Patrick J. Hensley, Andrew C. James, Peng Wang, Stephen E. Strup, Robert J. McDonald, Donglin Yan, William H. St. Clair und Derek B. Allison. „Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters“. Cancers 13, Nr. 9 (29.04.2021): 2157. http://dx.doi.org/10.3390/cancers13092157.
Der volle Inhalt der QuelleYang, Jianqiang, Fanghui Chen, Fan Yang und Yong Teng. „Abstract 3061: A positive feedback loop between GLS1 and c-Myc drives tumor aggressiveness“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 3061. http://dx.doi.org/10.1158/1538-7445.am2024-3061.
Der volle Inhalt der QuelleAhmed, Shanzay, Peter John, Rehan Zafar Paracha, Attya Bhatti und Monica Guma. „Docking and Molecular Dynamics Study to Identify Novel Phytobiologics from Dracaena trifasciata against Metabolic Reprogramming in Rheumatoid Arthritis“. Life 12, Nr. 8 (29.07.2022): 1148. http://dx.doi.org/10.3390/life12081148.
Der volle Inhalt der QuelleKono, Michihito, Nobuya Yoshida, Kayaho Maeda und George C. Tsokos. „Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells“. Proceedings of the National Academy of Sciences 115, Nr. 10 (20.02.2018): 2478–83. http://dx.doi.org/10.1073/pnas.1714717115.
Der volle Inhalt der QuelleBeręsewicz-Haller, Małgorzata, Olga Krupska, Paweł Bochomulski, Danuta Dudzik, Anita Chęcińska, Wojciech Hilgier, Coral Barbas, Krzysztof Zablocki und Barbara Zablocka. „Mitochondrial Metabolism behind Region-Specific Resistance to Ischemia-Reperfusion Injury in Gerbil Hippocampus. Role of PKCβII and Phosphate-Activated Glutaminase“. International Journal of Molecular Sciences 22, Nr. 16 (07.08.2021): 8504. http://dx.doi.org/10.3390/ijms22168504.
Der volle Inhalt der QuelleMyint, Zin, Patrick J. Hensley, Andrew Callaway James, Peng Wang, Stephen Strup, Donglin Yan, William H. St Clair, Robert S. DiPaola und Derek B. Allison. „Immunohistochemical evaluation of glutaminase expression in prostate adenocarcinoma and correlation with clinicopathologic parameters.“ Journal of Clinical Oncology 39, Nr. 6_suppl (20.02.2021): 251. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.251.
Der volle Inhalt der QuelleSyarifin, Andi N. K., Sri W. A. Jusman und Mohamad Sadikin. „Gene expression and enzyme activities of carbonic anhydrase and glutaminase in rat kidneys induced by chronic systemic hypoxia“. Medical Journal of Indonesia 24, Nr. 3 (09.11.2015): 139–45. http://dx.doi.org/10.13181/mji.v24i3.1190.
Der volle Inhalt der QuelleHage, Maha El, Justine Masson, Agnès Conjard-Duplany, Bernard Ferrier, Gabriel Baverel und Guy Martin. „Brain Slices from Glutaminase-Deficient Mice Metabolize Less Glutamine: A Cellular Metabolomic Study with Carbon 13 NMR“. Journal of Cerebral Blood Flow & Metabolism 32, Nr. 5 (29.02.2012): 816–24. http://dx.doi.org/10.1038/jcbfm.2012.22.
Der volle Inhalt der QuelleAkar, Hamurcu und Donmez-Altuntas. „The Effects on Proliferation of siRNA-Mediated GLS1 Inhibition in MDA-MB 231 Breast Cancer Cells“. Proceedings 40, Nr. 1 (26.12.2019): 25. http://dx.doi.org/10.3390/proceedings2019040025.
Der volle Inhalt der QuelleFu, Jiayao, Yiping Pu, Baoli Wang, Hui Li, Xiujuan Yang, Lisong Xie, Huan Shi et al. „Pharmacological Inhibition of Glutaminase 1 Normalized the Metabolic State and CD4+ T Cell Response in Sjogren’s Syndrome“. Journal of Immunology Research 2022 (15.02.2022): 1–13. http://dx.doi.org/10.1155/2022/3210200.
Der volle Inhalt der QuelleCoen, Chad, Jizhi Yan, Caner Saygin, Nicole Arellano, Mirielle Nauman, Katarzyna Zawieracz, Daniele Vanni et al. „Glutamine Metabolism Is Altered in Myeloproliferative Neoplasms and Represents a Potential Novel Therapeutic Target“. Blood 142, Supplement 1 (28.11.2023): 6350. http://dx.doi.org/10.1182/blood-2023-189731.
Der volle Inhalt der QuelleYoshikawa, Sachiko, Manabu Nagao, Ryuji Toh, Masakazu Shinohara, Takuya Iino, Yasuhiro Irino, Makoto Nishimori et al. „Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling“. American Journal of Physiology-Heart and Circulatory Physiology 322, Nr. 5 (01.05.2022): H749—H761. http://dx.doi.org/10.1152/ajpheart.00692.2021.
Der volle Inhalt der QuelleFeng, Yifan, Xi Yang, Jinhai Huang, Minqian Shen, Liyang Wang, Xiuping Chen, Yuanzhi Yuan, Chunqiong Dong, Xiaoping Ma und Fei Yuan. „Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages“. Oxidative Medicine and Cellular Longevity 2022 (19.03.2022): 1–19. http://dx.doi.org/10.1155/2022/1106313.
Der volle Inhalt der QuelleXu, Lingfan, Yu Yin, Yanjing Li, Xufeng Chen, Yan Chang, Hong Zhang, Juan Liu et al. „A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer“. Proceedings of the National Academy of Sciences 118, Nr. 13 (22.03.2021): e2012748118. http://dx.doi.org/10.1073/pnas.2012748118.
Der volle Inhalt der QuelleShibuya, Aya, Neil Margulis, Romain Christiano, Tobias C. Walther und Charles Barlowe. „The Erv41–Erv46 complex serves as a retrograde receptor to retrieve escaped ER proteins“. Journal of Cell Biology 208, Nr. 2 (12.01.2015): 197–209. http://dx.doi.org/10.1083/jcb.201408024.
Der volle Inhalt der QuelleXiong, Jian, Thi Thu Trang Luu, Kartik Venkatachalam, Guangwei Du und Michael X. Zhu. „Glutamine Produces Ammonium to Tune Lysosomal pH and Regulate Lysosomal Function“. Cells 12, Nr. 1 (24.12.2022): 80. http://dx.doi.org/10.3390/cells12010080.
Der volle Inhalt der QuelleAbdel-Magid, Ahmed F. „Glutaminase GLS1 Inhibitors as Potential Cancer Treatment“. ACS Medicinal Chemistry Letters 7, Nr. 3 (Februar 2016): 207–8. http://dx.doi.org/10.1021/acsmedchemlett.6b00016.
Der volle Inhalt der QuelleGuba, B. S., und V. V. Lyubimov. „Relationship between the effective saturation energy and the amplification diagram of GLS1 and GLS2 neodymium glasses“. Soviet Journal of Quantum Electronics 20, Nr. 9 (30.09.1990): 1075–78. http://dx.doi.org/10.1070/qe1990v020n09abeh007407.
Der volle Inhalt der QuelleLee, You Won, Hun Mi Choi, Seung Yeon Oh, Eun Ji Lee, Kyoung-Ho Pyo, Jae Hwan Kim, Youngseon Byeon et al. „Abstract LB544: Targeting adaptive metabolic program as a novel treatment approach for TKIs-failed ALK-positive NSCLCs“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): LB544. http://dx.doi.org/10.1158/1538-7445.am2022-lb544.
Der volle Inhalt der QuelleJovanovic, Katarina K., Léa Fléchon, Mairead Reidy, Jihye Park, Xavier Leleu, Irene M. Ghobrial, Thierry Facon, Bruno Quesnel und Salomon Manier. „MYC Overexpressing Multiple Myeloma Are Dependent on GLS1“. Blood 134, Supplement_1 (13.11.2019): 853. http://dx.doi.org/10.1182/blood-2019-128484.
Der volle Inhalt der QuelleRojo-Báez, Indira, Raymundo S. García-Estrada, Josefina León-Félix, J. Adriana Sañudo-Barajas und Raúl Allende-Molar. „EXPRESIÓN GÉNICA DURANTE EL PROCESO DE INFECCIÓN DE Colletotrichum truncatum (SCHWEIN.) EN PAPAYA MARADOL“. Revista Fitotecnia Mexicana 44, Nr. 2 (28.06.2021): 221. http://dx.doi.org/10.35196/rfm.2021.2.221.
Der volle Inhalt der QuelleSponagel, Jasmin, Shanshan Zhang, Prakash Chinnaiyan, Joshua Rubin und Joseph Ippolito. „TBIO-01. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA“. Neuro-Oncology 22, Supplement_3 (01.12.2020): iii467. http://dx.doi.org/10.1093/neuonc/noaa222.830.
Der volle Inhalt der QuelleLiu, Haixin, Haolun Tian, Pengcheng Hao, Huimin Du, Kun Wang, Yudong Qiu, Xiangrui Yin et al. „PoRVA G9P[23] and G5P[7] infections differentially promote PEDV replication by reprogramming glutamine metabolism“. PLOS Pathogens 20, Nr. 6 (21.06.2024): e1012305. http://dx.doi.org/10.1371/journal.ppat.1012305.
Der volle Inhalt der QuelleKim, Sewha, Do Hee Kim, Woo-Hee Jung und Ja Seung Koo. „Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer“. Endocrine-Related Cancer 20, Nr. 3 (18.03.2013): 339–48. http://dx.doi.org/10.1530/erc-12-0398.
Der volle Inhalt der QuelleSponagel, Jasmin, Shanshan Zhang, Cheryl Frankfater, Jill Jones, Din Selmanovic, Prakash Chinnaiyan, Joshua B. Rubin und Joseph E. Ippolito. „FSMP-19. SEX DIFFERENCES IN REDOX REGULATION UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA“. Neuro-Oncology Advances 3, Supplement_1 (01.03.2021): i19—i20. http://dx.doi.org/10.1093/noajnl/vdab024.082.
Der volle Inhalt der QuelleChattopadhyaya, Sikta, Raghu Nagalingam, Pavit Narhan und Michael Czubryt. „Regulation of GLS1 Expression by Scleraxis in Cardiac Fibroblasts“. FASEB Journal 34, S1 (April 2020): 1. http://dx.doi.org/10.1096/fasebj.2020.34.s1.05913.
Der volle Inhalt der QuelleXia, Xichun, Guangchao Cao, Guodong Sun, Leqing Zhu, Yixia Tian, Yueqi Song, Chengbin Guo et al. „GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis“. Journal of Clinical Investigation 130, Nr. 10 (24.08.2020): 5180–96. http://dx.doi.org/10.1172/jci129269.
Der volle Inhalt der QuelleChen, Weihua, Weifeng Wang, Jun Zhang, Guoqiang Liao, Jie Bai, Bo Yang, Mingyue Tan und Hua Gong. „Qici Sanling Decoction Suppresses Glutamine Consumption and Bladder Cancer Cell Growth through Inhibiting c-Myc Expression“. Journal of Oncology 2022 (11.01.2022): 1–9. http://dx.doi.org/10.1155/2022/7985468.
Der volle Inhalt der QuelleKrishna, Gayathri, Vinod Soman Pillai und Mohanan Valiya Veettil. „Upregulation of GLS1 Isoforms KGA and GAC Facilitates Mitochondrial Metabolism and Cell Proliferation in Epstein–Barr Virus Infected Cells“. Viruses 12, Nr. 8 (27.07.2020): 811. http://dx.doi.org/10.3390/v12080811.
Der volle Inhalt der QuelleNaka, I., J. Saegusa, K. Uto, Y. Yamamoto, Y. Ichise, H. Yamada, K. Akashi et al. „SAT0011 COMBINED INHIBITION OF AUTOPHAGY AND GLUTAMINE METABOLISM SUPPRESSES CELL GROWTH OF RA SYNOVIOCYTES AND AMELIORATES ARTHRITIS IN SKG MICE“. Annals of the Rheumatic Diseases 79, Suppl 1 (Juni 2020): 935.2–936. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1661.
Der volle Inhalt der QuellePoonaki, Elham, Ann-Christin Nickel, Mehdi Shafiee Ardestani, Lars Rademacher, Marilyn Kaul, Evgeny Apartsin, Sven G. Meuth, Ali Gorji, Christoph Janiak und Ulf Dietrich Kahlert. „CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells“. International Journal of Molecular Sciences 23, Nr. 10 (13.05.2022): 5479. http://dx.doi.org/10.3390/ijms23105479.
Der volle Inhalt der QuelleXu, Kangdi, Jun Ding, Lingfeng Zhou, Dazhi Li, Jia Luo, Wenchao Wang, Mingge Shang, Bingyi Lin, Lin Zhou und Shusen Zheng. „SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis“. Cells 12, Nr. 1 (21.12.2022): 25. http://dx.doi.org/10.3390/cells12010025.
Der volle Inhalt der QuelleLang, Liwei, Fang Wang, Chloe Shay, Yonggang Ke, Nabil Saba und Yong Teng. „Abstract 3026: Inhibition of glutaminolysis overcomes metabolic adaptation to devimistat treatment“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 3026. http://dx.doi.org/10.1158/1538-7445.am2022-3026.
Der volle Inhalt der QuelleOzcan, Selahattin C., Aydan Mutlu, Tugba H. Altunok, Yunus Gurpinar, Aybike Sarioglu, Sabire Guler, Robertino J. Muchut et al. „Simultaneous inhibition of PFKFB3 and GLS1 selectively kills KRAS-transformed pancreatic cells“. Biochemical and Biophysical Research Communications 571 (September 2021): 118–24. http://dx.doi.org/10.1016/j.bbrc.2021.07.070.
Der volle Inhalt der QuelleXi, Jianbo, Yaocheng Sun, Meiting Zhang, Zhenzhong Fa, Yanya Wan, Zhenyu Min, Hong Xu, Chengkai Xu und Jianjun Tang. „GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway“. Experimental Cell Research 381, Nr. 1 (August 2019): 1–9. http://dx.doi.org/10.1016/j.yexcr.2019.04.005.
Der volle Inhalt der QuelleJo, Michiko, Keiichi Koizumi, Mizuho Suzuki, Daisuke Kanayama, Yurie Watanabe, Hiroaki Gouda, Hisashi Mori et al. „Design, synthesis, structure–activity relationship studies, and evaluation of novel GLS1 inhibitors“. Bioorganic & Medicinal Chemistry Letters 87 (Mai 2023): 129266. http://dx.doi.org/10.1016/j.bmcl.2023.129266.
Der volle Inhalt der QuelleOkada, Takuya, Kaho Yamabe, Michiko Jo, Yuko Sakajiri, Tomokazu Shibata, Ryusuke Sawada, Yoshihiro Yamanishi et al. „Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity“. Bioorganic & Medicinal Chemistry Letters 93 (September 2023): 129438. http://dx.doi.org/10.1016/j.bmcl.2023.129438.
Der volle Inhalt der QuelleLam, Elaine T., Lih-Jen Su, Maren Salzmann-Sullivan, Steven K. Nordeen und Thomas W. Flaig. „Preclinical evaluation of teleglenastat (CB-839) in prostate cancer.“ Journal of Clinical Oncology 41, Nr. 6_suppl (20.02.2023): 378. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.378.
Der volle Inhalt der QuelleLi, Lingzhi, Changying Jiang, Lucy Jayne Navsaria, Yang Liu, Angela Leeming, Michael Wang und Yixin Yao. „Targeting Glutamine Metabolism Overcomes Resistance to Targeted Therapies in Refractory Mantle Cell Lymphoma“. Blood 136, Supplement 1 (05.11.2020): 25–26. http://dx.doi.org/10.1182/blood-2020-140736.
Der volle Inhalt der QuelleMoncada, Salvador, E. Annie Higgs und Sergio L. Colombo. „Fulfilling the metabolic requirements for cell proliferation“. Biochemical Journal 446, Nr. 1 (27.07.2012): 1–7. http://dx.doi.org/10.1042/bj20120427.
Der volle Inhalt der QuelleMatre, Polina, Ismael Samudio, Rodrigo Jacamo, Ying Wang, Jing Wang, R. Eric Davis, Xiaohua Su et al. „Unraveling The Molecular and Metabolic Basis For Glutamine Addiction In Leukemias“. Blood 122, Nr. 21 (15.11.2013): 606. http://dx.doi.org/10.1182/blood.v122.21.606.606.
Der volle Inhalt der QuelleWu, Shuai, Takeshi Fukumoto, Jianhuang Lin, Timothy Nacarelli, Yemin Wang, Dionzie Ong, Heng Liu et al. „Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma“. Nature Cancer 2, Nr. 2 (11.01.2021): 189–200. http://dx.doi.org/10.1038/s43018-020-00160-x.
Der volle Inhalt der QuelleCai, Wei-Feng, Cixiong Zhang, Yu-Qing Wu, Gui Zhuang, Zhiyun Ye, Chen-Song Zhang und Sheng-Cai Lin. „Glutaminase GLS1 senses glutamine availability in a non-enzymatic manner triggering mitochondrial fusion“. Cell Research 28, Nr. 8 (22.06.2018): 865–67. http://dx.doi.org/10.1038/s41422-018-0057-z.
Der volle Inhalt der QuelleGao, Chuan-Cheng, Qin-Qin Xu, Feng-Jun Xiao, Hua Wang, Chu-Tse Wu und Li-Sheng Wang. „NUDT21 suppresses the growth of small cell lung cancer by modulating GLS1 splicing“. Biochemical and Biophysical Research Communications 526, Nr. 2 (Mai 2020): 431–38. http://dx.doi.org/10.1016/j.bbrc.2020.03.089.
Der volle Inhalt der QuelleHenry, Christophe, Dimitri Gorge-Bernat, Pascal Pannier, Isabelle Meaux, Jane Cheng, Fangxian Sun, Olivier Pasquier et al. „Abstract 6033: RA123, a new GLS1 allosteric inhibitor demonstrates in vitro and in vivo activity in multiple myeloma models“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 6033. http://dx.doi.org/10.1158/1538-7445.am2023-6033.
Der volle Inhalt der QuelleSponagel, Jasmin, Shanshan Zhang, Jill Jones, Prakash Chinnaiyan, Joshua Rubin und Joseph Ippolito. „TAMI-37. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA“. Neuro-Oncology 22, Supplement_2 (November 2020): ii221. http://dx.doi.org/10.1093/neuonc/noaa215.925.
Der volle Inhalt der Quelle